Does Polivy Provide A Cure For DLBCL? Too Early To Say, Argue NICE Experts
A Draft 'No' To Roche’s Lymphoma Contender
Roche receives initial knockback for lymphoma treatment which could rival CAR-T therapies.
You may also be interested in...
Huge economic shock to sector could be quickly alleviated by early payment of R&D Tax Credits, says BIA.
Costs will be an issue, but not today; industry and healthcare systems are working at breakneck speed to catch up with the deadly virus.
More studies are being launched into possible treatments for patients hospitalised with COVID-19, with Roche launching a Phase III, placebo-controlled trial of Actemra.